Your browser doesn't support javascript.
loading
Cardiovascular Outcome Trials of Incretin Therapy (Dipeptidyl Peptidase-4 Inhibitors/Glucagon-Like Peptide-1 Receptor Agonist)
Journal of Lipid and Atherosclerosis ; : 32-41, 2018.
Artículo en Coreano | WPRIM | ID: wpr-714786
ABSTRACT
In 2008, the United States Food and Drug Administration issued guidance which mandated long-term cardiovascular outcome trials (CVOTs) to assess the safety of new antidiabetic drugs for type 2 diabetes. Since 2008, three CVOTs that have studied dipeptidyl peptidase-4 (DPP-4) inhibitors and four CVOTs of a glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) have been reported. Each of the completed CVOTs showed the noninferiority of respective drugs to placebo for primary CV composite endpoint. Among them, liraglutide and semaglutide showed a reduction of major adverse cardiovascular events. However, the mechanisms for the observed cardiovascular differences between DPP-4 inhibitors and GLP-1RA, and across individual GLP-1RA are not clearly understood. Therefore, this review will summarize the CVOTs of the DPP-4 inhibitors and GLP-1RA, interpretation of cardioprotective results of incretin-based therapy and the possible mechanism of action.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: United States Food and Drug Administration / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Inhibidores de la Dipeptidil-Peptidasa IV / Incretinas / Liraglutida / Hipoglucemiantes Tipo de estudio: Ensayo Clínico Controlado / Guía de Práctica Clínica Idioma: Coreano Revista: Journal of Lipid and Atherosclerosis Año: 2018 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: United States Food and Drug Administration / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Inhibidores de la Dipeptidil-Peptidasa IV / Incretinas / Liraglutida / Hipoglucemiantes Tipo de estudio: Ensayo Clínico Controlado / Guía de Práctica Clínica Idioma: Coreano Revista: Journal of Lipid and Atherosclerosis Año: 2018 Tipo del documento: Artículo